Track topics on Twitter Track topics that are important to you
Eureka 93 Inc. (CSE: ERKA, “Eureka93”) announced today that the Board of Directors has approved the appointment of Peter Ostapchuk as Chief Financial Officer, effective October 24, 2019.
“With experience in financial reporting and related disclosures, restructuring and creating shareholder value, Mr. Ostapchuk has the breadth of knowledge to drive our renewed transformation” said Seann Poli and Owen Kenney, Co-Chief Executive Officers of Eureka93. “Mr. Ostapchuk also brings experience in corporate governance, business strategy, public company regulatory disclosures, mergers and acquisitions, and enterprise risk management.”
Mr. Ostapchuk is a graduate of McMaster University, a Chartered Professional Accountant (CPA-Chartered Accountant), an accredited ICD.D director through the Institute of Corporate Directors, Audit Committee Certified (ACC) with the Directors College of Canada, and designated as a Certified Information Technology Professional (CITP).
“Mr. Ostapchuk’s involvement as Chief Financial Officer will lead to better outcomes for organization-wide performance improvements. His initial priority will be to complete and file second and third quarter financial statements, management, discussion and analysis (“MD&A”), and certifications as at June 30, 2019 and September 30, 2019 respectively, to remove the Cease Trade Order (“CTO”) issued by the Ontario Securities Commission on September 5, 2019” said Seann Poli.
Eureka 93 Inc. (Eureka93) is a vertically integrated life sciences company focused on the cultivation, extraction, and distribution of cannabis and hemp-derived cannabidiol (CBD) through it’s Health Canada licensed Artiva facility in Ottawa, Canada, and of hemp-derived CBD in its Montana, USA, location. This multi-faceted company is dedicated to producing the highest-quality products for its customers, including full-plant extract, distillate, and isolate. Leveraging high volume extraction processes, research, and scientific expertise across cannabis and hemp-derived CBD, Eureka93 leads with ingenuity, from the ground up.For more information, please visit: Eureka93.com
Media and Investors
Seann Poli, Co-CEO
Owen Kenney, Co-CEO
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...
Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.